The use of microvessel density in assessing human urological tumours

BJU International

Volumn 87, Issue 9, 2001, Pages 866-875

  Goddard, J C ^a,b   Sutton, C D ^a   Berry, D P ^a   O'Byrne, K J ^a   Kockelbergh, R C ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; MONOCLONAL ANTIBODY; VON WILLEBRAND FACTOR;

CELL SPECIFICITY; CORRELATION ANALYSIS; DATA BASE; DIAGNOSTIC PROCEDURE; ENDOTHELIUM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; REVIEW; TUMOR RECURRENCE; URINARY TRACT CANCER;

HUMANS; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; SENSITIVITY AND SPECIFICITY; UROLOGIC NEOPLASMS;

EID: 0035723583     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2001.02181.x     Document Type: Review

References (82)

1. Tumor angiogenesis: Therapeutic implications
2. What is the evidence that tumors are angiogenesis dependent?
3. Tumoural vascularity as a prognostic factor in cancer patients: The evidence continues to grow
4. A synthetic, nitrogenated antimetastatic and anti-angiogenic compound with low toxicity in vivo
5. Angiogenesis in bladder cancer: Relationship between microvessel density and tumor prognosis
6. Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer
7. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas
8. Microvessel density as a prognostic marker for transitional cell carcinoma of the bladder
9. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer
10. Prognostic significance of angiogenesis and immunoreactivity of cathepsin D and type IV collagen in high-grade stage T1 primary bladder cancer
11. Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder
12. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy
13. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting
14. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy
15. Vascular density is a predictor of cancer-specific survival in prostatic carcinoma
16. Immunohistochemical determination of tumor angiogenesis measured by the maximal microvessel density in human prostate cancer
17. Tumor angiogenesis correlates with progression after radical pro-statectomy but not with pathologic stage in Gleason sum 5-7 adenocarcinoma of the prostate
18. Evaluation of microvessel density by computerised image analysis in human renal cell carcinoma. Correlation to pT category, nuclear grade, proliferative activity and occurrence of metastasis
19. Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma
20. Prognostic significance of microvessel count in low stage renal cell carcinoma
21. Evaluation of the prognostic significance of microvessel count and tumor size in renal cell carcinoma
22. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease
23. Neovascularization in clinical stage A testicular germ cell tumor: Prediction of metastatic disease
24. P53 and angiogenesis in invasive bladder cancer
25. Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder
26. Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: Lack of significance for microvessel density analysis
27. Microvessel density in prostate cancer: Lack of correlation with tumor grade, pathologic stage, and clinical outcome
28. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma
29. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma
30. Microvessel density in renal cell carcinoma: Lack of prognostic significance
31. The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer
32. Tumor angiogenesis and metastasis: Correlation in invasive renal cell carcinoma
33. Quantitative assessment of vascular surface density in renal cell carcinomas
34. Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma
35. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism
36. New marker for blood vessels in human ovarian and endometrial cancers
37. Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis, and tumor progression
38. Quantitative morphometric analysis of the microcirculation in prostate carcinoma
39. Comparison of microscopic vascularity in benign and malignant prostate tissue
40. Tumor-associated angiogenesis in prostate cancer
41. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
42. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity
43. Topography of neovascularity in human prostate carcinoma
44. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: Correlation with Gleason's score, microvessel density, and epithelial cell proliferation
45. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies
46. Microvessel density in core biopsies of prostatic adenocarcinoma: A stage predictor?
47. Relationship between prostate specific antigen density, microvessel density and prostatic volume in benign prostatic hyperplasia and advanced prostatic carcinoma
48. Prostate cancer microvessels: A novel method for three-dimensional reconstruction and analysis
49. An analysis of microvessel density, androgen receptor, p53 and HER-2/neu expression and Gleason score in prostate cancer. Preliminary results and therapeutic implications
50. Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma
51. Correlation between proliferation, apoptosis, and angiogenesis in prostate carcinoma and their relation to androgen ablation
52. Expression of platelet-derived endothelial cell growth factor in prostatic adenocarcinoma
53. Comparison of microvascularization in diagnostic needle biopsies and radical prostatectomies in prostate carcinoma
54. Quantification by competitive quantitative RT-PCR of VEGF121 and VEGF165 in renal cell carcinoma
55. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
56. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
57. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors
58. Novel methods for the determination of the angiogenic activity of human tumors
59. Relation of neovascularisation to metastasis of non-small-cell lung cancer
60. Angiogenesis in the early human chorion and in the primary placenta of the Macaque monkey
61. Tumor angiogenesis: A quantitative method for histologic grading
62. The vascular patterns of tumors
63. Is a histological section representative of whole tumour vascularity in breast cancer?
64. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation
65. Assessment of angiogenesis in breast carcinoma: An important factor in prognosis?
66. Examining the technique of angiogenesis assessment in invasive breast cancer
67. Heterogeneity and reproducibility of microvessel counts in breast cancer
68. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma
69. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma
70. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer
71. Association between tumour angiogenesis and tumour cell shedding into effluent venous blood during breast cancer surgery
72. Microvessel quantitation and prognosis in invasive breast carcinoma
73. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma
74. Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas
75. Endothelial area as a prognostic indicator for invasive breast carcinoma
76. Tumor angiogenesis in primary and metastatic colorectal cancers
77. Prognostic value of angiogenesis in operable non-small cell lung cancer
78. Angiogenesis in breast cancer: A comparative study of the observer variability of methods for determining microvessel density
79. Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma
80. Vascular Reactions of normal and malignant tumours in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants
81. Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis
82. Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer